Department of Radiology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Department of Radiology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Int J Mol Sci. 2022 Sep 5;23(17):10187. doi: 10.3390/ijms231710187.
Vestibular schwannomas are the most common tumor at the common cerebellopontine angle, followed by meningiomas. Differentiation of these tumors is critical because of the different surgical approaches required for treatment. Recent studies have demonstrated the utility of amide proton transfer (APT)-chemical exchange saturation transfer (CEST) imaging in evaluating malignant brain tumors. However, APT imaging has not been applied in benign tumors. Here, we explored the potential of APT in differentiating between schwannomas and meningiomas at the cerebellopontine angle. We retrospectively evaluated nine patients with schwannoma and nine patients with meningioma who underwent APT-CEST MRI from November 2020 to April 2022 pre-operation. All 18 tumors were histologically diagnosed. There was a significant difference in magnetization transfer ratio asymmetry (MTR) values (0.033 ± 0.012 vs. 0.021 ± 0.004; = 0.007) between the schwannoma and meningioma groups. Receiver operative curve analysis showed that MTR values clearly differentiated between the schwannoma and meningioma groups. At an MTR value threshold of 0.024, the diagnostic sensitivity, specificity, positive predictive value, and negative predictive values for MTR were 88.9%, 77.8%, 80.0%, and 87.5%, respectively. Our results demonstrated the ability of MTR values on APT-CEST imaging to discriminate patients with schwannomas from patients with meningiomas.
前庭神经鞘瘤是桥小脑角最常见的肿瘤,其次是脑膜瘤。由于治疗所需的手术方法不同,区分这些肿瘤至关重要。最近的研究表明酰胺质子转移(APT)-化学交换饱和转移(CEST)成像在评估恶性脑肿瘤方面具有实用性。然而,APT 成像尚未应用于良性肿瘤。在这里,我们探讨了 APT 在区分桥小脑角神经鞘瘤和脑膜瘤方面的潜力。我们回顾性评估了 2020 年 11 月至 2022 年 4 月期间接受 APT-CEST MRI 检查的 9 例神经鞘瘤和 9 例脑膜瘤患者。所有 18 个肿瘤均经组织学诊断。神经鞘瘤组和脑膜瘤组的磁化转移率不对称(MTR)值(0.033 ± 0.012 vs. 0.021 ± 0.004; = 0.007)有显著差异。受试者工作特征曲线分析显示,MTR 值可清楚地区分神经鞘瘤和脑膜瘤组。当 MTR 值阈值为 0.024 时,MTR 的诊断灵敏度、特异性、阳性预测值和阴性预测值分别为 88.9%、77.8%、80.0%和 87.5%。我们的研究结果表明,APT-CEST 成像上的 MTR 值能够区分神经鞘瘤患者和脑膜瘤患者。